Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen

被引:19
|
作者
Hsu, HY
Chang, MH
Hsieh, RP
Ni, YH
Chi, WK
机构
[1] NATL TAIWAN UNIV,COLL MED,DEPT EMERGENCY MED,TAIPEI 10764,TAIWAN
[2] NATL TAIWAN UNIV,COLL MED,DEPT PEDIAT,TAIPEI 10764,TAIWAN
[3] NATL TAIWAN UNIV,COLL MED,DEPT LAB MED,TAIPEI 10764,TAIWAN
[4] DEV CTR BIOTECHNOL,TAIPEI,TAIWAN
关键词
D O I
10.1002/hep.510240607
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The immune responses to hepatitis B vaccine were studied in 11 hepatitis B surface antigen (HBsAg) carrier children who had cleared HBsAg but failed to develop hepatitis B surface antigen antibodies (anti-HBs) in sera (group 1), 5 HBsAg carrier children who had cleared HBsAg and developed detectable anti-HBs in sera (group 2), and 5 healthy subjects seronegative for all hepatitis B virus (HBV) markers (group 3), After receiving three doses of HB vaccine, group 1 subjects failed to develop detectable anti-HBs, Subsequently, each subject of the three groups was given one dose of the same vaccine for a cellular immunity study, and a measurable proliferation of peripheral blood mononuclear cells (PBMC) to HBsAg was detected in 1 of 8 (12.5%), 0 of 5, and 4 of 5 (80%) of the cases in each group, respectively, after vaccination, The removal of CD8(+) cells enhanced the HBsAg blastogenic response in group 3 but did not reverse the unresponsiveness in group 1 and group 2 subjects, The addition of interleukin (IL)-2 in culture reversed unresponsiveness in all cases except one case in group 1, Compared with before vaccination, PBMC from group 2 subjects produced significantly less interferon gamma (IFN-gamma) and more IL-4 in response to HBsAg after vaccination, a cytokine response not observed in group 1 subjects, HLA typing indicated that 3 of 10 patients in group 1 (30%) and 1 of 5 patients in group 2 (20%) had HLA-DRw14-DRw52, a marker previously linked to low anti-HBs response to hepatitis B vaccine in Taiwan, We conclude that the underlying causes of poor anti-HBs response in group 1 subjects are multifactorial, including specific failure of antigen presentation or T-cell activation, or the lack of T helper (Th)2 cell-like response to HBsAg, HLA-DRw14-DRw52 does not confer absolute nonresponsiveness to HBsAg, These patients are not benefited by hepatitis B immunization.
引用
收藏
页码:1355 / 1360
页数:6
相关论文
共 50 条
  • [1] Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen
    Rahman, F
    Dahmen, A
    Herzog-Hauff, S
    Böcher, WO
    Galle, PR
    Löhr, HF
    HEPATOLOGY, 2000, 31 (02) : 521 - 527
  • [2] POSTNATAL INFECTIVITY OF HEPATITIS-B SURFACE ANTIGEN-CARRIER MOTHERS
    BEASLEY, RP
    HWANG, LY
    JOURNAL OF INFECTIOUS DISEASES, 1983, 147 (02): : 185 - 190
  • [3] The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B
    Demiroren, Kaan
    Kocamaz, Halil
    Dogan, Yasar
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2015, 26 (01): : 36 - 41
  • [4] HUMORAL AND CELLULAR IMMUNE-RESPONSES BY NORMAL INDIVIDUALS TO HEPATITIS-B SURFACE-ANTIGEN VACCINATION
    FILION, LG
    SAGINUR, R
    SZCZERBAK, N
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1988, 71 (03): : 405 - 409
  • [5] CELLULAR AND HUMORAL IMMUNITY TO HEPATITIS-B SURFACE ANTIGEN IN ACTIVE CHRONIC HEPATITIS
    LEE, WM
    REED, WD
    MITCHELL, CG
    GALBRAITH, RM
    EDDLESTON, ALWF
    ZUCKERMAN, AJ
    WILLIAMS, R
    BRITISH MEDICAL JOURNAL, 1975, 1 (5960): : 705 - 708
  • [6] Serum Hepatitis B Surface Antigen Levels Predict Surface Antigen Loss in Hepatitis B e Antigen Seroconverters
    Tseng, Tai-Chung
    Liu, Chun-Jen
    Su, Tung-Hung
    Wang, Chia-Chi
    Chen, Chi-Ling
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Kao, Jia-Horng
    GASTROENTEROLOGY, 2011, 141 (02) : 517 - U600
  • [7] Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B
    Wai-Kay Seto
    Danny Ka-Ho Wong
    James Fung
    Ivan Fan-Ngai Hung
    John Chi-Hang Yuen
    Teresa Tong
    Ching-Lung Lai
    Man-Fung Yuen
    Hepatology International, 2013, 7 : 119 - 126
  • [8] Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B
    Seto, Wai-Kay
    Wong, Danny Ka-Ho
    Fung, James
    Hung, Ivan Fan-Ngai
    Yuen, John Chi-Hang
    Tong, Teresa
    Lai, Ching-Lung
    Yuen, Man-Fung
    HEPATOLOGY INTERNATIONAL, 2013, 7 (01) : 119 - 126
  • [9] Hepatitis B core antigen and hepatitis B surface antigen in a patient with active hepatitis B and HIV
    Cardenas, A
    JOURNAL OF HEPATOLOGY, 2005, 42 (02) : 284 - 284
  • [10] A NATIONWIDE VACCINATION PROGRAM IN ITALY AGAINST HEPATITIS-B VIRUS-INFECTION IN INFANTS OF HEPATITIS-B SURFACE ANTIGEN-CARRIER MOTHERS
    STROFFOLINI, T
    PASQUINI, P
    MELE, A
    VACCINE, 1989, 7 (02) : 152 - 154